INFUSYSTEM HOLDINGS, INC (INFU) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 15.30M USD | Liabilities, Current |
| Cash and equivalents | 964.00K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 27.20M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 5.52M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $15.30M | $964.00K | (m) | $27.20M | $5.52M | (m) |
| 2026-03-31 | (m) | $17.14M | $2.11M | (m) | $23.98M | $5.83M | (m) |
| 2025-12-31 | (m) | $20.18M | $3.19M | (m) | $22.90M | $5.39M | (m) |
| 2025-09-30 | (m) | $18.72M | $955.00K | (m) | $24.31M | $5.59M | (m) |
| 2025-06-30 | (m) | $15.86M | $720.00K | (m) | $24.48M | $5.67M | (m) |
| 2025-03-31 | (m) | $15.97M | $1.51M | (m) | $23.89M | $6.09M | (m) |
| 2024-12-31 | (m) | $17.66M | $527.00K | (m) | $21.16M | $6.53M | (m) |
| 2024-09-30 | (m) | $16.94M | $380.00K | (m) | $22.76M | $6.70M | (m) |
| 2024-06-30 | (m) | $15.88M | $146.00K | (m) | $21.32M | $6.84M | (m) |
| 2024-03-31 | (m) | $17.31M | $822.00K | (m) | $20.54M | $6.25M | (m) |
| 2023-12-31 | (m) | $15.71M | $231.00K | (m) | $19.83M | $6.40M | (m) |
| 2023-09-30 | (m) | $14.28M | $161.00K | (m) | $19.45M | $6.09M | (m) |
| 2023-06-30 | (m) | $12.87M | $134.00K | (m) | $18.87M | $5.71M | (m) |
| 2023-03-31 | (m) | $13.93M | $256.00K | (m) | $18.27M | $5.64M | (m) |
| 2022-12-31 | (m) | $14.47M | $165.00K | (m) | $16.87M | $4.82M | (m) |
| 2022-09-30 | (m) | $12.73M | $363.00K | (m) | $16.11M | $4.86M | (m) |
| 2022-06-30 | (m) | $14.43M | $311.00K | (m) | $15.84M | $4.88M | (m) |
| 2022-03-31 | (m) | $13.94M | $405.00K | (m) | $16.39M | $3.88M | (m) |
| 2021-12-31 | (m) | $12.90M | $186.00K | (m) | $15.40M | $3.94M | (m) |
| 2021-09-30 | (m) | $14.48M | $165.00K | (m) | $15.85M | $3.71M | (m) |
| 2021-06-30 | (m) | $15.85M | $164.00K | (m) | $15.53M | $3.72M | (m) |
| 2021-03-31 | (m) | $12.16M | $2.76M | (m) | $14.69M | $3.23M | (m) |
| 2020-12-31 | (m) | $23.00M | $9.65M | (m) | $14.72M | $3.00M | (m) |
| 2020-09-30 | (m) | $19.70M | $1.94M | (m) | $13.93M | $3.97M | (m) |
| 2020-06-30 | (m) | $20.12M | $482.00K | (m) | $16.61M | $4.26M | (m) |
| 2020-03-31 | (m) | $23.80M | $305.00K | (m) | $13.98M | $4.23M | (m) |
| 2019-12-31 | (m) | $21.85M | $2.65M | (m) | $12.10M | $2.90M | (m) |
| 2019-09-30 | (m) | $21.81M | $3.16M | (m) | $11.46M | $2.77M | (m) |
| 2019-06-30 | (m) | $20.53M | $1.70M | (m) | $11.22M | $2.74M | (m) |
| 2019-03-31 | (m) | $18.48M | $1.90M | (m) | $10.47M | $2.55M | (m) |
| 2018-12-31 | (m) | $14.79M | $4.32M | (m) | $9.59M | $2.25M | (m) |
| 2018-09-30 | (m) | $14.66M | $3.88M | (m) | $10.04M | $1.99M | (m) |
| 2018-06-30 | (m) | $11.67M | $2.36M | (m) | $9.89M | $1.99M | (m) |
| 2018-03-31 | (m) | $10.91M | $1.53M | (m) | $11.09M | $2.06M | (m) |
| 2017-12-31 | (m) | $12.47M | $3.47M | (m) | $11.38M | $1.76M | (m) |
| 2017-09-30 | (m) | $9.95M | $803.00K | (m) | $10.97M | $1.87M | (m) |
| 2017-06-30 | (m) | $10.99M | $76.00K | (m) | $11.55M | $1.96M | (m) |
| 2017-03-31 | (m) | $40.11M | $194.00K | (m) | $12.08M | $2.13M | (m) |
| 2016-12-31 | (m) | $16.44M | $3.40M | (m) | $11.58M | $2.17M | (m) |
| 2016-09-30 | (m) | $14.65M | $1.07M | (m) | $12.22M | $2.06M | (m) |
| 2016-06-30 | (m) | $13.85M | $805.00K | (m) | $16.95M | $2.10M | (m) |
| 2016-03-31 | (m) | $15.65M | $569.00K | (m) | $15.36M | $2.62M | (m) |
| 2015-12-31 | (m) | $15.29M | $818.00K | (m) | $14.21M | $1.92M | (m) |
| 2015-09-30 | (m) | $14.81M | $989.00K | (m) | $13.58M | $1.91M | (m) |
| 2015-06-30 | (m) | $16.24M | $791.00K | (m) | $12.30M | $1.90M | (m) |
| 2015-03-31 | (m) | $13.06M | $3.22M | (m) | $11.50M | $1.98M | (m) |
| 2014-12-31 | (m) | $14.73M | $515.00K | (m) | $10.30M | $1.76M | (m) |
| 2014-09-30 | (m) | $12.11M | $1.90M | (m) | $11.51M | $1.59M | (m) |
| 2014-06-30 | (m) | $10.54M | $1.04M | (m) | $10.77M | $1.49M | (m) |
| 2014-03-31 | (m) | $12.94M | $496.00K | (m) | $12.10M | $1.40M | (m) |
| 2013-12-31 | (m) | $13.04M | $1.14M | (m) | $10.70M | $1.23M | (m) |
| 2013-09-30 | (m) | $10.39M | $908.00K | (m) | $9.29M | $1.34M | (m) |
| 2013-06-30 | (m) | $9.74M | $102.00K | (m) | $9.44M | $1.38M | (m) |
| 2013-03-31 | (m) | $11.11M | $472.00K | (m) | $9.57M | $1.38M | (m) |
| 2012-12-31 | (m) | $10.20M | $2.33M | (m) | $8.51M | $1.34M | (m) |
| 2012-09-30 | (m) | $32.76M | $1.46M | (m) | $7.63M | $3.80M | (m) |
| 2012-06-30 | (m) | $14.01M | $804.00K | (m) | $7.75M | $3.88M | (m) |
| 2012-03-31 | (m) | $12.12M | $0.00 | (m) | $8.32M | $3.92M | (m) |
| 2011-12-31 | (m) | $13.13M | $799.00K | (m) | $7.35M | $3.22M | (m) |
| 2011-09-30 | (m) | $10.98M | $433.00K | (m) | $7.98M | $2.15M | (m) |
| 2011-06-30 | (m) | $10.91M | $1.72M | (m) | $6.73M | $1.41M | (m) |
| 2011-03-31 | (m) | (m) | $3.18M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $12.38M | $5.01M | (m) | $6.68M | $1.70M | (m) |
| 2010-09-30 | (m) | (m) | $4.69M | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | $3.02M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $7.75M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $11.51M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |